Pharmaceutical News

RSS

Oral antioxidant formulation before medical imaging may minimize cell damage

A unique formulation of antioxidants taken orally before imaging with ionizing radiation minimizes cell damage, noted researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities

Health officials in Venezuela announced on Friday the number of confirmed H1N1 cases in the country has grown to more than 200, the Associated Press/Seattle Times reports.

29 Mar 2011

AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions

AmeriCares and AstraZeneca have teamed to deliver critical medicines to help people living with chronic diseases throughout the United States. AstraZeneca has donated $5 million in cardiovascular and gastrointestinal medications to AmeriCares in support of its Domestic Medical Assistance Program.

29 Mar 2011

Nycomed submits teduglutide MAA to EMA for SBS treatment

NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported that Nycomed, a global pharmaceutical company, headquartered in Switzerland, has submitted a Marketing Authorization Application to the European Medicines Agency for clearance to market teduglutide as a once-daily subcutaneous treatment for short bowel syndrome.

29 Mar 2011

Cardinal Health, APhA partner to prevent prescription medication abuse

During the American Pharmacists Association's Annual Meeting and Exposition in Seattle, the Cardinal Health Foundation and APhA announced a partnership to encourage pharmacists and student pharmacists to take an active role in preventing the abuse and misuse of prescription medications.

29 Mar 2011

Atypical antipsychotics is a safe mental health medication for nursing home residents

Conventional antipsychotics, antidepressants and benzodiazepines often administered to nursing home residents are no safer than atypical antipsychotics and may carry increased risks, according to an article in CMAJ.

29 Mar 2011

Scientists develop new model that can predict early adverse drug reactions

All medications have side-effects from common aspirin to herbal remedies and from standard anticancer drugs to experimental immunosuppressants. However, predicting important side effects, serious adverse drug reactions, ADRs, is with current understanding almost impossible.

29 Mar 2011

USPTO issues Notice of Allowance to Modular's green surfactant patent application

Modular Genetics, Inc. is a sustainable chemistry company utilizing advanced technology in synthetic biology to produce specialty chemicals that are cost competitive, provide superior performance and are environmentally friendly. Modular's lead product is a "green" surfactant initially targeting the personal care market.

29 Mar 2011

New pill may protect DNA from radiation damage

The Japanese nuclear crisis has caused a surge in the demand of potassium iodide, causing shortages not only in Japan, but as far away as California, western Canada, and even southeastern Russia. Although potassium iodide does not provide generalized radiation protection because it only shields the thyroid, manufacturers and pharmacies are being bombarded with orders as the radiation hysteria mounts.

28 Mar 2011

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

28 Mar 2011

Metagenics announces 2011 schedule for educational programs in lifestyle medicine

Metagenics Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, announced today the 2011 schedule for educational programs in lifestyle medicine as well as for certification programs for its FirstLine Therapy, a turnkey, lifestyle medicine program.

28 Mar 2011

Drugs can prevent risk of breast cancer in women, experts say

Drugs could be used to prevent breast cancer in women at high risk of the disease in the same way that statins are used for heart disease if trials looking at ways of predicting risk are successful, according to an international panel of cancer experts.

28 Mar 2011

RDY introduces Levocetirizine tablets in the U.S. market

Dr. Reddy's Laboratories has launched Levocetirizine tablets, a bioequivalent generic version of Xyzal tablets in the US market. The United States Food & Drug Administration approved Dr. Reddy's ANDA for Levocetirizine tablets on February 24, 2011.

28 Mar 2011

DAW prescriptions can increase annual health system costs to $7.7 billion

Approximately five percent of prescriptions submitted by CVS Caremark Pharmacy Benefit Management members in a 30-day period during 2009 included a "dispense as written" designation.

28 Mar 2011

MRF: FDA's decision on Yervoy offers new treatment options for patients with melanoma

Thirteen years of waiting is now over for melanoma patients. That's how long it's been since the last therapy became available to treat the most lethal form of skin cancer – melanoma. The FDA today announced approval of Yervoy, an immunotherapy treatment for advanced melanoma.

28 Mar 2011

U.S. FDA approves Yervoy to treat patients with late-stage melanoma

The U.S. Food and Drug Administration today approved Yervoy to treat patients with late-stage melanoma, the most dangerous type of skin cancer.

28 Mar 2011

University of Aberdeen, TPP enter agreement to develop novel future medicines

TPP Global Development Ltd has announced an agreement with the University of Aberdeen to collaborate on the development of novel pre-clinical intellectual property originated within the University.

28 Mar 2011

Study establishes strong link between nicotine and diabetes complications

Scientists today reported the first strong evidence implicating nicotine as the main culprit responsible for persistently elevated blood sugar levels - and the resulting increased risk of serious health complications - in people who have diabetes and smoke.

28 Mar 2011

CHPA issues statement in response to anti-consumer law on cold and allergy drugs

The Consumer Healthcare Products Association today issued the following statement in response to passage of Senate Bill 437: "Legislation sponsored by Senator Percy Malone and now signed into law places new, onerous burdens on Arkansas families and makes it more difficult for those with common colds and allergies, even basic aches and pains, to get the medications they need. Unfortunately, Senate Bill 437 falls short of the common-sense approach Arkansans expect from their leaders."

28 Mar 2011

FDA approves ipilimumab for metastatic melanoma treatment

The U.S. Food and Drug Administration announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer.

28 Mar 2011

Pharmaceutical News

Oral antioxidant formulation before medical imaging may minimize cell damage

Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities

AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions

Nycomed submits teduglutide MAA to EMA for SBS treatment

Cardinal Health, APhA partner to prevent prescription medication abuse

Atypical antipsychotics is a safe mental health medication for nursing home residents

Scientists develop new model that can predict early adverse drug reactions

USPTO issues Notice of Allowance to Modular's green surfactant patent application

New pill may protect DNA from radiation damage

Cancer drug Gleevec may hold promise against scleroderma: Study

Metagenics announces 2011 schedule for educational programs in lifestyle medicine

Drugs can prevent risk of breast cancer in women, experts say

RDY introduces Levocetirizine tablets in the U.S. market

DAW prescriptions can increase annual health system costs to $7.7 billion

MRF: FDA's decision on Yervoy offers new treatment options for patients with melanoma

U.S. FDA approves Yervoy to treat patients with late-stage melanoma

University of Aberdeen, TPP enter agreement to develop novel future medicines

Study establishes strong link between nicotine and diabetes complications

CHPA issues statement in response to anti-consumer law on cold and allergy drugs

FDA approves ipilimumab for metastatic melanoma treatment

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News